首页|HER2阴性乳腺癌化疗患者复发转移的影响因素及风险预测模型构建

HER2阴性乳腺癌化疗患者复发转移的影响因素及风险预测模型构建

扫码查看
目的 探讨人表皮生长因子受体-2(HER2)阴性乳腺癌化疗患者复发转移的影响因素,并构建风险预测模型.方法 回顾性分析180例接受新辅助化疗的HER2阴性乳腺癌患者病历资料和随访资料,根据2年内复发转移情况将患者分为复发转移组(35例)和未复发转移组(145例).采用Logistic回归分析HER2阴性乳腺癌化疗患者复发转移的影响因素,依据回归分析结果构建风险预测模型,计算一致性指数(C-index)检验模型准确性.绘制受试者工作曲线(ROC),以曲线下面积(AUC)检验风险预测模型对HER2阴性乳腺癌化疗患者复发转移的预测价值.结果 复发转移组和未复发转移组在月经状态、临床分期、p53蛋白、Ki-67、VEGF方面比较,差异有统计学意义(P<0.05).Logistic回归分析显示,月经状态、临床分期、p53蛋白、Ki-67、VEGF是HER2阴性乳腺癌化疗患者复发转移的影响因素(P<0.05).基于上述因素构建风险预测模型,结果显示该列线图模型的校准曲线和Y=X直线相近,模型校准度良好,C-in-dex 值为 0.844,提示该模型具有良好区分度.绘制ROC曲线发现,列线图风险预测模型预测HER2阴性乳腺癌化疗患者复发转移的AUC为0.844.结论 月经状态、临床分期、p53蛋白、Ki-67、VEGF是HER2阴性乳腺癌化疗患者复发转移的影响因素,基于上述影响因素构建的风险预测模型可有效评估患者复发转移.
Influencing Factors and Risk Prediction Model Construction of Recurrence and Metasta-sis in HER2 Negative Breast Cancer Patients Underwent Chemotherapy
Objective To explore the factors influencing the recurrence and metastasis of breast cancer patients with negative human epidermal growth factor receptor-2(HER2)after chemotherapy,and to establish a risk prediction model.Methods The medical records and follow-up data of 180 HER2 negative breast cancer patients who received neoadjuvant chemotherapy were retrospectively analyzed.According to the recurrence and metastasis within 2 years,the patients were divided into the recurrence and metastasis group(35 cases)and the non recurrence and metastasis group(145 cases).Logistic regression was used to analyze the influencing factors of recurrence and metastasis in HER2 negative breast cancer patients undergoing chemotherapy.The risk prediction model was constructed based on the regression results,and the consistency index(C-index)was calculated to test the accuracy of the model.The ROC of the subjects was drawn,and the area under the curve(AUC)was used to test the predictive value of the risk prediction model for the recurrence and metastasis of HER2 negative breast cancer patients underwent chemother-apy.Results There was a statistically significant difference in menstrual status,clinical staging,p53 protein,Ki-67,and VEGF between the recurrence and non recurrence metastasis groups(P<0.05).Logistic regression analysis showed that menstrual sta-tus,clinical stage,p53 protein,Ki-67,VEGF were the influencing factors for recurrence and metastasis of HER2 negative breast cancer patients undergoing chemotherapy(P<0.05).Based on the above factors,a risk prediction model was constructed,and the results showed that the calibration curve of the column chart model was similar to the Y=X straight line.The model had good cal-ibration,with a C-index value of 0.844,indicating that the model had good discrimination.The ROC curve was drawn and it was found that the AUC of HER2 negative breast cancer patients with chemotherapy predicted by the nomogram risk prediction model was 0.844.Conclusion Menstrual status,clinical stage,p53 protein,Ki-67,VEGF are the influencing factors of recurrence and metastasis in HER2 negative breast cancer patients undergoing chemotherapy.The risk prediction model based on the above influ-encing factors can effectively evaluate the recurrence and metastasis of patients.

Breast cancerHuman epidermal growth factor receptor-2Recurrence and metastasisInfluencing factorsRisk prediction model

薛茗予、宋薇、杨柳

展开 >

450000 郑州大学第一附属医院

乳腺癌 人表皮生长因子受体-2 复发转移 影响因素 风险预测模型

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(6)